5:20 PM ET
8-K
Clinical Trial Data
Tectonic Therapeutic Clinical Trial Data
Tectonic Therapeutic announced favorable topline results from its Phase 1a clinical trial of TX2100, demonstrating that single ascending doses were generally safe and well-tolerated in healthy volunteers. The company also received FDA Fast Track designation and IND clearance to proceed with Phase 1b and Phase 2 trials in patients with Hereditary Hemorrhagic Telangiectasia (HHT).